CIK 0001824893
- Non-accelerated filer
- Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 301374889
- Phone
- +1 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Williams Charles O Chief Financial Officer | Grant or award · Option (right to buy) | +125,000 | 125,000 | ||
| 2023-02-01 | Yeh Wen-Chen Chief Scientific Officer | Grant or award · Option (right to buy) | +125,000 | 125,000 | ||
| 2022-12-15 | Yeh Wen-Chen Chief Scientific Officer | Grant or award | +9,578 | $0.41 | $4K | 229,138 |
| 2022-12-15 | Parker Craig C Chief Executive Officer | Grant or award | +9,578 | $0.41 | $4K | 9,578 |
| 2022-12-15 | Vanhove Geertrui Chief Medical Officer | Grant or award | +9,578 | $0.41 | $4K | 32,412 |
| 2022-12-15 | Williams Charles O Chief Financial Officer | Grant or award | +9,578 | $0.41 | $4K | 9,578 |
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale | −1,748,750 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale | −1,297,922 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale | −450,827 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale | −1,885,000 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale · Warrants (right to buy) | −582,916 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale · Warrants (right to buy) | −432,639 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale · Warrants (right to buy) | −150,275 | 0 | ||
| 2022-12-14 | BLUTT MITCHELL J MD 10% owner | Sale · Warrants (right to buy) | −144,666 | 0 | ||
| 2022-10-10 | Vanhove Geertrui Chief Medical Officer | Returned to the company · Option (right to buy) | −24,587 | 0 | ||
| 2022-10-10 | Vanhove Geertrui Chief Medical Officer | Returned to the company · Option (right to buy) | −10,427 | 0 | ||
| 2022-10-10 | Vanhove Geertrui Chief Medical Officer | Returned to the company · Option (right to buy) | −26,220 | 0 | ||
| 2022-10-10 | Vanhove Geertrui Chief Medical Officer | Returned to the company · Option (right to buy) | −1,760 | 0 | ||
| 2022-10-10 | Vanhove Geertrui Chief Medical Officer | Grant or award · Option (right to buy) | +26,220 | 26,220 | ||
| 2022-10-10 | Vanhove Geertrui Chief Medical Officer | Grant or award · Option (right to buy) | +10,427 | 10,427 |
Page 13 of 20 · 398 trades